ArticleCureus2026
Adrenal Masses in a Moroccan Tertiary Center: A 14-Year Retrospective Study of 200 Patients.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives Adrenal masses are increasingly detected and encompass a broad spectrum of clinical presentations and pathological diagnoses. This study aimed to describe the epidemiological, clinical, paraclinical, etiological, and therapeutic profiles of patients with adrenal masses. Materials and methods This single-center retrospective descriptive study included consecutive eligible patients hospitalized for adrenal masses at the Department of Endocrinology, Diabetology, Metabolic Diseases, and Nutrition of Hassan II University Hospital in Fez, Morocco, between January 2009 and January 2023. Data were retrospectively collected from medical records between January and February 2023. Results A total of 200 patients were included, with a mean age of 49 years and a predominance of female patients (n = 142, 71%). The most common circumstance of discovery was adrenal incidentaloma (n = 110, 55%). The etiological diagnoses were non-secreting adenoma (n = 73, 36.5%), pheochromocytoma (n = 33, 16.5%), Conn's adenoma (n = 22, 11%), cortisol-secreting adenoma (n = 20, 10%), adrenocortical carcinoma (n = 18, 9%), adrenal metastases (n = 13, 6.5%), adrenal cysts (n = 7, 3.5%), lymphoma (n = 5, 2.5%), myelolipoma (n = 4, 2%), ganglioneuroma (n = 2, 1%), schwannoma (n = 2, 1%), and oncocytic adenoma (n = 1, 0.5%). Surgical treatment was performed in 80 patients (40%), documented clinical and biological surveillance was performed in 43 patients (21.5%), and 10 patients (5%) received palliative treatment. Conclusion This study demonstrates the diversity of adrenal mass etiologies and clinical presentations and highlights the importance of a multidisciplinary diagnostic and therapeutic approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.